DOCK8 deficiency: clinical and immunological phenotype and treatment options-a review of 136 patients

SE Aydin, SS Kilic, C Aytekin, A Kumar… - Journal of clinical …, 2015 - Springer
Mutations in DOCK8 result in autosomal recessive Hyper-IgE syndrome with combined
immunodeficiency (CID). However, the natural course of disease, long-term prognosis, and …

Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985 …

RA Seger, T Gungor, BH Belohradsky… - Blood, The Journal …, 2002 - ashpublications.org
Treatment of chronic granulomatous disease (CGD) with myeloablative bone marrow
transplantation is considered risky. This study investigated complications and survival …

Hematologically important mutations: leukocyte adhesion deficiency (first update)

E Van De Vijver, A Maddalena, Ö Sanal… - Blood Cells, Molecules …, 2012 - Elsevier
Leukocyte adhesion deficiency (LAD) is an immunodeficiency caused by defects in the
adhesion of leukocytes (especially neutrophils) to the blood vessel wall. As a result, patients …

Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.

…, H Oechsler, B Belohradsky… - Journal of medical …, 1997 - jmg.bmj.com
We present clinical data on 558 patients with deletions within the DiGeorge syndrome
critical region of chromosome 22q11. Twenty-eight percent of the cases where parents had …

Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis

…, J Sawalle-Belohradsky, B Belohradsky… - Journal of Experimental …, 2011 - rupress.org
Chronic mucocutaneous candidiasis disease (CMCD) may be caused by autosomal
dominant (AD) IL-17F deficiency or autosomal recessive (AR) IL-17RA deficiency. Here …

[HTML][HTML] Chronic granulomatous disease: the European experience

JM van den Berg, E van Koppen, A Åhlin… - PloS one, 2009 - journals.plos.org
CGD is an immunodeficiency caused by deletions or mutations in genes that encode
subunits of the leukocyte NADPH oxidase complex. Normally, assembly of the NADPH …

[PDF][PDF] Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity

Y Minegishi, M Saito, T Morio, K Watanabe… - Immunity, 2006 - cell.com
Summary Tyrosine kinase 2 (Tyk2) is a nonreceptor tyrosine kinase that belongs to the
Janus kinase (Jak) family. Here we identified a homozygous Tyk2 mutation in a patient who …

Clinical picture and treatment of 2212 patients with common variable immunodeficiency

B Gathmann, N Mahlaoui, L Gérard… - Journal of Allergy and …, 2014 - Elsevier
Background Common variable immunodeficiency (CVID) is an antibody deficiency with an
equal sex distribution and a high variability in clinical presentation. The main features …

[HTML][HTML] Efficacy of gene therapy for X-linked severe combined immunodeficiency

S Hacein-Bey-Abina, J Hauer, A Lim… - … England Journal of …, 2010 - Mass Medical Soc
Background The outcomes of gene therapy to correct congenital immunodeficiencies are
unknown. We reviewed long-term outcomes after gene therapy in nine patients with X-linked …

Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype

…, Y Camcioglu, LA Kerns, B Belohradsky… - Blood, The Journal …, 2016 - ashpublications.org
Since their discovery in patients with autosomal dominant (AD) chronic mucocutaneous
candidiasis (CMC) in 2011, heterozygous STAT1 gain-of-function (GOF) mutations have …